(Q48932292)

English

The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease

scientific article published in January 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anthony H V Schapira

1

object named as

Anthony H V Schapira

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

language of work or name

0 references

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

23 Suppl 3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

S3

1 reference

1 July 2019

S515-20

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22146

21 January 2018

Brain Peroxidase and Catalase in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22146

21 January 2018

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22146

21 January 2018

Neuroprotection and dopamine agonists

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22146

21 January 2018

Slowing Parkinson's disease progression: recent dopamine agonist trials

1 reference

https://api.crossref.org/works/10.1002%2FMDS.22146

21 January 2018

Identifiers

10.1002/MDS.22146

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/18781678

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48932292&oldid=2214728891"